Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2023-08-24 00:00:00 ET · period of report 2023-08-24 · accession 0001140361-23-041191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-24 | 2023-08-24 | ADMA | KWON YOUNG | Dir | P - Purchase | $3.90 | +25.0K | 277.4K | +10% | +$97.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-24 | P | A | 25,000 | $3.90 | 277,401 | D | — | — | (F1) Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023, that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date and (ii) 251,586 shares of common stock owned by the reporting person. |